Works matching IS 08876924 AND DT 2014 AND VI 28 AND IP 12

Results: 30

Mesenchymal stromal cells inhibit proliferation of virus-specific CD8(+) T cells.

Published in:

2014

By:

Malcherek, G;
Jin, N;
Hückelhoven, A G;
Mani, J;
Wang, L;
Gern, U;
Diehlmann, A;
Wuchter, P;
Schmitt, A;
Chen, B;
Ho, A D;
Schmitt, M

Publication type:

journal article

CD34(+)CD38(-)CD58(-) cells are leukemia-propagating cells in Philadelphia chromosome-positive acute lymphoblastic leukemia.

Published in:

2014

By:

Kong, Y;
Chang, Y-J;
Liu, Y-R;
Wang, Y-Z;
Jiang, Q;
Jiang, H;
Qin, Y-Z;
Hu, Y;
Lai, Y-Y;
Duan, C-W;
Hong, D-L;
Huang, X-J

Publication type:

Letter

Calreticulin mutations and long-term survival in essential thrombocythemia.

Published in:

Leukemia (08876924), 2014, v. 28, n. 12, p. 2300, doi. 10.1038/leu.2014.148

By:

Tefferi, A;
Wassie, E A;
Lasho, T L;
Finke, C;
Belachew, A A;
Ketterling, R P;
Hanson, C A;
Pardanani, A;
Gangat, N;
Wolanskyj, A P

Publication type:

Article

A matched comparison of cyclophosphamide, bortezomib and dexamethasone (CVD) versus risk-adapted cyclophosphamide, thalidomide and dexamethasone (CTD) in AL amyloidosis.

Published in:

Leukemia (08876924), 2014, v. 28, n. 12, p. 2304, doi. 10.1038/leu.2014.218

By:

Venner, C P;
Gillmore, J D;
Sachchithanantham, S;
Mahmood, S;
Lane, T;
Foard, D;
Rannigan, L;
Gibbs, S D J;
Pinney, J H;
Whelan, C J;
Lachmann, H J;
Hawkins, P N;
Wechalekar, A D

Publication type:

Article

Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia.

Published in:

Leukemia (08876924), 2014, v. 28, n. 12, p. 2427, doi. 10.1038/leu.2014.304

By:

Allegra, D;
Bilan, V;
Garding, A;
Zucknick, M;
Döhner, H;
Stilgenbauer, S;
Kuchenbauer, F;
Mertens, D

Publication type:

Article

Risk of myeloid neoplasms after solid organ transplantation.

Published in:

Leukemia (08876924), 2014, v. 28, n. 12, p. 2317, doi. 10.1038/leu.2014.132

By:

Morton, L M;
Gibson, T M;
Clarke, C A;
Lynch, C F;
Anderson, L A;
Pfeiffer, R;
Landgren, O;
Weisenburger, D D;
Engels, E A

Publication type:

Article

High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial.

Published in:

Leukemia (08876924), 2014, v. 28, n. 12, p. 2367, doi. 10.1038/leu.2014.137

By:

Rossille, D;
Gressier, M;
Damotte, D;
Maucort-Boulch, D;
Pangault, C;
Semana, G;
Le Gouill, S;
Haioun, C;
Tarte, K;
Lamy, T;
Milpied, N;
Fest, T

Publication type:

Article

Phase II study of pomalidomide in high-risk relapsed and refractory multiple myeloma.

Published in:

Leukemia (08876924), 2014, v. 28, n. 12, p. 2413, doi. 10.1038/leu.2014.248

By:

Usmani, S Z;
Zhang, Q;
Stratton, K;
Qu, P;
Yaccoby, S;
Hansen, E;
Steward, D;
Panozzo, S;
Petty, N;
Hoering, A;
Waheed, S;
Van Rhee, F;
Crowley, J;
Barlogie, B

Publication type:

Article

Mesenchymal stromal cells inhibit proliferation of virus-specific CD8+ T cells.

Published in:

Leukemia (08876924), 2014, v. 28, n. 12, p. 2388, doi. 10.1038/leu.2014.273

By:

Malcherek, G;
Jin, N;
Hückelhoven, A G;
Mani, J;
Wang, L;
Gern, U;
Diehlmann, A;
Wuchter, P;
Schmitt, A;
Chen, B;
Ho, A D;
Schmitt, M

Publication type:

Article

The prognostic importance of the presence of more than one focal lesion in spine MRI of patients with asymptomatic (smoldering) multiple myeloma.

Published in:

Leukemia (08876924), 2014, v. 28, n. 12, p. 2402, doi. 10.1038/leu.2014.230

By:

Kastritis, E;
Moulopoulos, L A;
Terpos, E;
Koutoulidis, V;
Dimopoulos, M A

Publication type:

Article

WTAP is a novel oncogenic protein in acute myeloid leukemia.

Published in:

Leukemia (08876924), 2014, v. 28, n. 12, p. 2427, doi. 10.1038/leu.2014.290

By:

Bansal, H;
Yihua, Q;
Iyer, S P;
Ganapathy, S;
Proia, D A;
Penalva, L O;
Uren, P J;
Suresh, U;
Carew, J S;
Karnad, A B;
Weitman, S;
Tomlinson, G E;
Rao, M K;
Kornblau, S M;
Bansal, S

Publication type:

Article

CD34+CD38−CD58− cells are leukemia-propagating cells in Philadelphia chromosome-positive acute lymphoblastic leukemia.

Published in:

Leukemia (08876924), 2014, v. 28, n. 12, p. 2398, doi. 10.1038/leu.2014.228

By:

Kong, Y;
Chang, Y-J;
Liu, Y-R;
Wang, Y-Z;
Jiang, Q;
Jiang, H;
Qin, Y-Z;
Hu, Y;
Lai, Y-Y;
Duan, C-W;
Hong, D-L;
Huang, X-J

Publication type:

Article

Melphalan and dexamethasone with or without bortezomib in newly diagnosed AL amyloidosis: a matched case-control study on 174 patients.

Published in:

Leukemia (08876924), 2014, v. 28, n. 12, p. 2311, doi. 10.1038/leu.2014.227

By:

Palladini, G;
Milani, P;
Foli, A;
Vidus Rosin, M;
Basset, M;
Lavatelli, F;
Nuvolone, M;
Obici, L;
Perlini, S;
Merlini, G

Publication type:

Article

FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma.

Published in:

Leukemia (08876924), 2014, v. 28, n. 12, p. 2376, doi. 10.1038/leu.2014.126

By:

Sehgal, L;
Mathur, R;
Braun, F K;
Wise, J F;
Berkova, Z;
Neelapu, S;
Kwak, L W;
Samaniego, F

Publication type:

Article

Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients.

Published in:

Leukemia (08876924), 2014, v. 28, n. 12, p. 2344, doi. 10.1038/leu.2014.136

By:

Sakurai, M;
Kunimoto, H;
Watanabe, N;
Fukuchi, Y;
Yuasa, S;
Yamazaki, S;
Nishimura, T;
Sadahira, K;
Fukuda, K;
Okano, H;
Nakauchi, H;
Morita, Y;
Matsumura, I;
Kudo, K;
Ito, E;
Ebihara, Y;
Tsuji, K;
Harada, Y;
Harada, H;
Okamoto, S

Publication type:

Article

Next generation treatment of acute graft-versus-host disease.

Published in:

Leukemia (08876924), 2014, v. 28, n. 12, p. 2283, doi. 10.1038/leu.2014.195

By:

Magenau, J;
Reddy, P

Publication type:

Article

Prompt all-trans retinoic acid administration and early death in acute promyelocytic leukemia: what does the evidence say?

Published in:

Leukemia (08876924), 2014, v. 28, n. 12, p. 2425, doi. 10.1038/leu.2014.274

By:

Rashidi, A;
Fisher, S I

Publication type:

Article

Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status.

Published in:

Leukemia (08876924), 2014, v. 28, n. 12, p. 2292, doi. 10.1038/leu.2014.272

By:

Schmidt, M;
Rinke, J;
Schäfer, V;
Schnittger, S;
Kohlmann, A;
Obstfelder, E;
Kunert, C;
Ziermann, J;
Winkelmann, N;
Eigendorff, E;
Haferlach, T;
Haferlach, C;
Hochhaus, A;
Ernst, T

Publication type:

Article

Primary acute myeloid leukemia cells with IDH1 or IDH2 mutations respond to a DOT1L inhibitor in vitro.

Published in:

Leukemia (08876924), 2014, v. 28, n. 12, p. 2403, doi. 10.1038/leu.2014.235

By:

Sarkaria, S M;
Christopher, M J;
Klco, J M;
Ley, T J

Publication type:

Article

Notch and NF-kB signaling pathways regulate miR-223/FBXW7 axis in T-cell acute lymphoblastic leukemia.

Published in:

Leukemia (08876924), 2014, v. 28, n. 12, p. 2324, doi. 10.1038/leu.2014.133

By:

Kumar, V;
Palermo, R;
Talora, C;
Campese, A F;
Checquolo, S;
Bellavia, D;
Tottone, L;
Testa, G;
Miele, E;
Indraccolo, S;
Amadori, A;
Ferretti, E;
Gulino, A;
Vacca, A;
Screpanti, I

Publication type:

Article

Relationship of different platelet response criteria and patient outcomes in a romiplostim myelodysplastic syndromes trial.

Published in:

Leukemia (08876924), 2014, v. 28, n. 12, p. 2418, doi. 10.1038/leu.2014.253

By:

Platzbecker, U;
Sekeres, M A;
Kantarjian, H;
Giagounidis, A;
Mufti, G J;
Jia, C;
Yang, A S;
Fenaux, P

Publication type:

Article

Monoclonal B-cell lymphocytosis is characterized by mutations in CLL putative driver genes and clonal heterogeneity many years before disease progression.

Published in:

Leukemia (08876924), 2014, v. 28, n. 12, p. 2395, doi. 10.1038/leu.2014.226

By:

Ojha, J;
Secreto, C;
Rabe, K;
Ayres-Silva, J;
Tschumper, R;
Dyke, D V;
Slager, S;
Fonseca, R;
Shanafelt, T;
Kay, N;
Braggio, E

Publication type:

Article

Still no certainty about the role of upfront bortezomib among patients with AL amyloidosis.

Published in:

Leukemia (08876924), 2014, v. 28, n. 12, p. 2273, doi. 10.1038/leu.2014.271

By:

Dispenzieri, A

Publication type:

Article

AKT-induced reactive oxygen species generate imatinib-resistant clones emerging from chronic myeloid leukemia progenitor cells.

Published in:

Leukemia (08876924), 2014, v. 28, n. 12, p. 2416, doi. 10.1038/leu.2014.249

By:

Nieborowska-Skorska, M;
Flis, S;
Skorski, T

Publication type:

Article

Early death in acute promyelocytic leukemia (APL) in French centers: a multicenter study in 399 patients.

Published in:

Leukemia (08876924), 2014, v. 28, n. 12, p. 2422, doi. 10.1038/leu.2014.240

By:

Rahmé, R;
Thomas, X;
Recher, C;
Vey, N;
Delaunay, J;
Deconinck, E;
Hirsch, P;
Bordessoule, D;
Micol, J-B;
Stamatoullas, A;
Mariette, C;
Pautas, C;
Bories, P;
Marolleau, J-P;
Hunault-Berger, M;
Fegueux, N;
Raffoux, E;
Dombret, H;
Degos, L;
Fenaux, P

Publication type:

Article

Pre-leukemic evolution of hematopoietic stem cells: the importance of early mutations in leukemogenesis.

Published in:

Leukemia (08876924), 2014, v. 28, n. 12, p. 2276, doi. 10.1038/leu.2014.211

By:

Corces-Zimmerman, M R;
Majeti, R

Publication type:

Article

A revised definition for cure of childhood acute lymphoblastic leukemia.

Published in:

Leukemia (08876924), 2014, v. 28, n. 12, p. 2336, doi. 10.1038/leu.2014.142

By:

Pui, C H;
Pei, D;
Campana, D;
Cheng, C;
Sandlund, J T;
Bowman, W P;
Hudson, M M;
Ribeiro, R C;
Raimondi, S C;
Jeha, S;
Howard, S C;
Bhojwani, D;
Inaba, H;
Rubnitz, J E;
Metzger, M L;
Gruber, T A;
Coustan-Smith, E;
Downing, J R;
Leung, W H;
Relling, M V

Publication type:

Article

Therapeutic targeting of naturally presented myeloperoxidase-derived HLA peptide ligands on myeloid leukemia cells by TCR-transgenic T cells.

Published in:

Leukemia (08876924), 2014, v. 28, n. 12, p. 2355, doi. 10.1038/leu.2014.131

By:

Klar, R;
Schober, S;
Rami, M;
Mall, S;
Merl, J;
Hauck, S M;
Ueffing, M;
Admon, A;
Slotta-Huspenina, J;
Schwaiger, M;
Stevanović, S;
Oostendorp, R A J;
Busch, D H;
Peschel, C;
Krackhardt, A M

Publication type:

Article

Lymphodepletion followed by infusion of suicide gene-transduced donor lymphocytes to safely enhance their antitumor effect: a phase I/II study.

Published in:

Leukemia (08876924), 2014, v. 28, n. 12, p. 2406, doi. 10.1038/leu.2014.237

By:

Maury, S;
Rosenzwajg, M;
Redjoul, R;
Marcais, A;
Xhaard, A;
Cherai, M;
Cabanne, L;
Churlaud, G;
Suarez, F;
Socié, G;
Gregoire, L;
Debbache, K;
Bernard, C;
Beaumont, J-L;
Azar, N;
Boyer, O;
Roudot-Thoraval, F;
Cohen, J L;
Cordonnier, C;
Lemoine, F M

Publication type:

Article

Five gene probes carry most of the discriminatory power of the 70-gene risk model in multiple myeloma.

Published in:

Leukemia (08876924), 2014, v. 28, n. 12, p. 2410, doi. 10.1038/leu.2014.232

By:

Heuck, C J;
Qu, P;
van Rhee, F;
Waheed, S;
Usmani, S Z;
Epstein, J;
Zhang, Q;
Edmondson, R;
Hoering, A;
Crowley, J;
Barlogie, B

Publication type:

Article

Works matching IS 08876924 AND DT 2014 AND VI 28 AND IP 12

Mesenchymal stromal cells inhibit proliferation of virus-specific CD8(+) T cells.

CD34(+)CD38(-)CD58(-) cells are leukemia-propagating cells in Philadelphia chromosome-positive acute lymphoblastic leukemia.

Calreticulin mutations and long-term survival in essential thrombocythemia.

A matched comparison of cyclophosphamide, bortezomib and dexamethasone (CVD) versus risk-adapted cyclophosphamide, thalidomide and dexamethasone (CTD) in AL amyloidosis.

Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia.

Risk of myeloid neoplasms after solid organ transplantation.

High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial.

Phase II study of pomalidomide in high-risk relapsed and refractory multiple myeloma.

Mesenchymal stromal cells inhibit proliferation of virus-specific CD8<sup>+</sup> T cells.

The prognostic importance of the presence of more than one focal lesion in spine MRI of patients with asymptomatic (smoldering) multiple myeloma.

WTAP is a novel oncogenic protein in acute myeloid leukemia.

CD34<sup>+</sup>CD38<sup>−</sup>CD58<sup>−</sup> cells are leukemia-propagating cells in Philadelphia chromosome-positive acute lymphoblastic leukemia.

Melphalan and dexamethasone with or without bortezomib in newly diagnosed AL amyloidosis: a matched case-control study on 174 patients.

FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma.

Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients.

Next generation treatment of acute graft-versus-host disease.

Prompt all-trans retinoic acid administration and early death in acute promyelocytic leukemia: what does the evidence say?

Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status.

Primary acute myeloid leukemia cells with IDH1 or IDH2 mutations respond to a DOT1L inhibitor in vitro.

Notch and NF-kB signaling pathways regulate miR-223/FBXW7 axis in T-cell acute lymphoblastic leukemia.

Relationship of different platelet response criteria and patient outcomes in a romiplostim myelodysplastic syndromes trial.

Monoclonal B-cell lymphocytosis is characterized by mutations in CLL putative driver genes and clonal heterogeneity many years before disease progression.

Still no certainty about the role of upfront bortezomib among patients with AL amyloidosis.

AKT-induced reactive oxygen species generate imatinib-resistant clones emerging from chronic myeloid leukemia progenitor cells.

Early death in acute promyelocytic leukemia (APL) in French centers: a multicenter study in 399 patients.

Pre-leukemic evolution of hematopoietic stem cells: the importance of early mutations in leukemogenesis.

A revised definition for cure of childhood acute lymphoblastic leukemia.

Therapeutic targeting of naturally presented myeloperoxidase-derived HLA peptide ligands on myeloid leukemia cells by TCR-transgenic T cells.

Lymphodepletion followed by infusion of suicide gene-transduced donor lymphocytes to safely enhance their antitumor effect: a phase I/II study.

Five gene probes carry most of the discriminatory power of the 70-gene risk model in multiple myeloma.